DE60115622D1 - Methoden und zusammensetzungen zur aufklärung von proteinexpressionsprofilen in zellen - Google Patents

Methoden und zusammensetzungen zur aufklärung von proteinexpressionsprofilen in zellen

Info

Publication number
DE60115622D1
DE60115622D1 DE60115622T DE60115622T DE60115622D1 DE 60115622 D1 DE60115622 D1 DE 60115622D1 DE 60115622 T DE60115622 T DE 60115622T DE 60115622 T DE60115622 T DE 60115622T DE 60115622 D1 DE60115622 D1 DE 60115622D1
Authority
DE
Germany
Prior art keywords
compositions
methods
protein expression
cells
explanation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60115622T
Other languages
English (en)
Other versions
DE60115622T2 (de
Inventor
J Link
Tatiana Seregina
Nicholas N Vahanian
James N Higginbotham
W Ramsey
Bradley J Powers
Sachet A Shukla
Bin Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
NewLink Genetics Inc
Original Assignee
NewLink Genetics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by NewLink Genetics Inc filed Critical NewLink Genetics Inc
Publication of DE60115622D1 publication Critical patent/DE60115622D1/de
Application granted granted Critical
Publication of DE60115622T2 publication Critical patent/DE60115622T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1051—Gene trapping, e.g. exon-, intron-, IRES-, signal sequence-trap cloning, trap vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biochemistry (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE60115622T 2000-03-20 2001-03-19 Methoden und zusammensetzungen zur aufklärung von proteinexpressionsprofilen in zellen Expired - Fee Related DE60115622T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19067800P 2000-03-20 2000-03-20
US190678P 2000-03-20
PCT/US2001/008770 WO2001070948A2 (en) 2000-03-20 2001-03-19 Methods and compositions for elucidating protein expression profiles in cells

Publications (2)

Publication Number Publication Date
DE60115622D1 true DE60115622D1 (de) 2006-01-12
DE60115622T2 DE60115622T2 (de) 2006-06-22

Family

ID=22702326

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60115622T Expired - Fee Related DE60115622T2 (de) 2000-03-20 2001-03-19 Methoden und zusammensetzungen zur aufklärung von proteinexpressionsprofilen in zellen

Country Status (8)

Country Link
EP (1) EP1268767B1 (de)
JP (1) JP2003527855A (de)
AT (1) ATE312173T1 (de)
AU (1) AU2001249267A1 (de)
CA (1) CA2403567A1 (de)
DE (1) DE60115622T2 (de)
MX (1) MXPA02009257A (de)
WO (1) WO2001070948A2 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1425416A4 (de) * 2001-08-24 2005-07-20 Health Research Inc Verfahren mit hohem durchsatz zur identifizierung von sequenz-tags
US20060094059A1 (en) * 2004-09-22 2006-05-04 Odyssey Thera, Inc. Methods for identifying new drug leads and new therapeutic uses for known drugs
US9646134B2 (en) 2010-05-25 2017-05-09 The Regents Of The University Of California Bambam: parallel comparative analysis of high-throughput sequencing data
KR102042253B1 (ko) 2010-05-25 2019-11-07 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 Ｂａｍｂａｍ：고처리율 서열분석 데이터의 병렬 비교 분석
CN113501861A (zh) * 2021-08-01 2021-10-15 青海瑞肽生物科技有限公司 一种高分辨质谱筛选牦牛胶原蛋白特征片段的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364783A (en) * 1990-05-14 1994-11-15 Massachusetts Institute Of Technology Retrovirus promoter-trap vectors
US5434065A (en) * 1993-05-06 1995-07-18 President And Fellows Of Harvard College In vivo selection of microbial virulence genes
US5922601A (en) * 1995-01-19 1999-07-13 Biotransplant, Inc. High efficiency gene trap selection of regulated genetic loci
US5866330A (en) * 1995-09-12 1999-02-02 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US6207371B1 (en) * 1996-10-04 2001-03-27 Lexicon Genetics Incorporated Indexed library of cells containing genomic modifications and methods of making and utilizing the same
US5994077A (en) * 1997-01-31 1999-11-30 The Board Of Trustees Of The Leland Stanford Junior University Flourescence-based isolation of differentially induced genes
AU7499198A (en) * 1997-05-21 1998-12-11 Johns Hopkins University, The Gene expression profiles in normal and cancer cells
ATE400660T1 (de) * 1998-03-27 2008-07-15 Lexicon Pharmaceuticals Inc Vektoren für genmutagenese und genentdeckung
AU3917600A (en) * 1999-03-25 2000-10-09 Massachusetts Institute Of Technology Retroviral vectors and methods for production and use thereof

Also Published As

Publication number Publication date
WO2001070948A2 (en) 2001-09-27
JP2003527855A (ja) 2003-09-24
EP1268767B1 (de) 2005-12-07
WO2001070948A3 (en) 2002-04-04
ATE312173T1 (de) 2005-12-15
MXPA02009257A (es) 2004-04-05
DE60115622T2 (de) 2006-06-22
AU2001249267A1 (en) 2001-10-03
EP1268767A2 (de) 2003-01-02
WO2001070948A9 (en) 2002-12-19
CA2403567A1 (en) 2001-09-27

Similar Documents

Publication Publication Date Title
DE60128916D1 (de) Neues, physiologisch aktives peptid und dessen verwendung
ATE510558T1 (de) Verwendung von biologisch aktivem hiv-1 tat, fragmenten oder derivaten davon, zur bestimmung und/oder aktivierung von antigen-präsentierenden zellen, und/oder zur abgabe von cargo-molekülen für impfung und/oder für behandlung von anderen erkrankungen
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
DE602005021770D1 (de) Indol-1-yl-essigsäurederivate
BR0311313A (pt) Derivados de diaril uréia úteis para o tratamento de doenças dependentes de proteìna cinase
UA90657C2 (ru) Ловушки vegf и их терапевтические применения
EA200600076A1 (ru) Композиции и способы увеличения активности теломеразы
BRPI0418251A (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais
NO20055209D0 (no) Peptabody for cancerbehandling
ATE476654T1 (de) Plattform für protein-profiling
BRPI0413574A (pt) aplicação de polipeptìdeos da famìlia cupredoxina na terapia do cáncer
NO20033144L (no) Modul¶re transfeksjonssystemer
BRPI0413438A (pt) derivados de pirimidilpirrol ativos como inibidores de cinase
CY1114724T1 (el) Ανασυνδυασμενες πρωτεϊνες ελαστασης και μεθοδοι βιομηχανικης κατασκευης και χρηση αυτων
ATE345780T1 (de) Lyophilisierende zusammensetzung von wirkstoff- verkapselnder polymer-mizelle und verfahren zu ihrer herstellung
DE112004000961D2 (de) Verwendung von Wirksubstanzen zur Vorbeugung oder Behandlung von Viruserkrankungen sowie Testsystem zum Auffinden solcher Wirksubstanzen
DE602004016950D1 (de) Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung
WO2004038381A3 (en) Methods for drug discovery, disease treatment, and diagnosis using metabolomics
DE60218843D1 (de) Verfahren zur identifizierung von mitteln zur behandlung von diabetes
DE60115622D1 (de) Methoden und zusammensetzungen zur aufklärung von proteinexpressionsprofilen in zellen
CY1111004T1 (el) Χρησιμες συνθεσεις για τη ρυθμιση της δρασης του γονιδιου της παρκινης
ATE344662T1 (de) Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen
ATE548048T1 (de) Oncomodulin zur behandlung von neurologishen erkrankungen
DE60114193D1 (de) Transfektionssystem
DE10394363D2 (de) Neue Chelidonin-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von pharmazeutischen Wirkstoffen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee